Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2018
February 2018, Vol 8, No 2
February 2018, Vol 8, No 2
A Dynamic FDA Has Led to More Rapid Cancer Drug Development
By
Wayne Kuznar
Cancer Drugs R&D
Read More ›
New Breast Cancer Treatment Strategies Highlighted at SABCS 2017
By
Phoebe Starr
Breast Cancer
,
SABCS 2017
Read More ›
The Butterfly Effect: Improving the Chemotherapy Visit Experience
By
Gail Thompson
Practice Operations
Read More ›
Authority Over Medical Practices—Something to Watch
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›
CDK4/CDK6 Inhibitors Effective in Older Women, but Have More Side Effects
By
Phoebe Starr
Breast Cancer
,
SABCS 2017
Read More ›
Switching on the Light: A Model Immunotherapy Program for Oncology Practices
By
Gail Thompson
Immunotherapy
Read More ›
Combining Immunotherapy and Radiotherapy Shows Good Synergy
Immunotherapy
Read More ›
Silent Patients Find Their Voices Through an Advocate’s Journey
By
Meg Barbor, MPH
Patients Perspectives
Read More ›
Managing Adverse Events Linked to Immune Checkpoint Inhibitors: What Is Your Knowledge Level?
By
Eileen Koutnik-Fotopoulos
Side-Effects Management
Read More ›
The Challenges of Oral Cancer Drugs Use and Side-Effects Management
By
Meg Barbor, MPH
Side-Effects Management
There is only one “king of the road” when it comes to dealing with the adverse side effects of oral cancer drugs, and that is not the healthcare professional, according to Christine B. Boers-Doets, MSc, of the Netherlands Leiden University Medical Center, author of
The TARGET System
, and creator of the
7 Pillars of Ultimate Drug Success
formula.
Read More ›
Page 1 of 2
1
2
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By
Dawn Holcombe, MBA, FACMPE, ACHE
3.
2023 Spotlight: Amgen
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes